glucagon in retatrutide Retatrutide: How the Triple Agonist Compares to Tirzepatide Retatrutide (LY3437943) | MyBioSource

"Fewer than 1 in 10 people who could benefit from a GLP-1 are taking one." "People living with obesity need treatment options that meet them where they are and for many, a once-daily pill that can be taken with no food or water restrictions can offer them greater flexibility in how they approach their treatment," she said in the same press release

They found that 9% had an outright deficiency and 16% exhibited a near deficiency. Many of these individuals were suffering from neurological symptoms (4)

Sourcing pressure has tightened following Health Canadas 2025 and 2026 advisories naming BPC-157 among unauthorized injectable peptides seized from Canadian sellers

Most experiments were performed in HCT-116 cells, with selected validation in HT-29 cells, and the findings may not be generalizable to the metabolic heterogeneity of colorectal cancer